Professor David Jayne
Professor of Clinical autoimmunity, Department of Medicine, University of Cambridge.
About this event
- Date and time Thu 21 Mar 2019 from 8:30am to 5:00pm
- Location Royal Society of Medicine
- Organised by Nephrology, UK Kidney Research, Consortium GN Clinical Study Group
This meeting explores current understanding of glomerular diseases with an autoimmune aetiology. It dissects the histological and pathological features that underpin this spectrum of diseases.
Therapeutic mechanisms, clinical trials and management strategies are explained, along with expert panel discussions.
Updates will include newer therapies in vasculitis, the evolving story of lupus nephritis and novel insights into the management of IgA nephropathy.
Topics include:
- Update on clinical trials in glomerulonephritis
- Review of therapeutic agents and immunosuppressant regimens
- Novel insights on renal biopsy in glomerular disease
- A forum for complex case-based discussion with an expert panel
Key speakers
Professor Rosanna Coppo
Regina Margherita Childrens university Hospital, Piazzo Polonia,Turin, Italy.
Dr Manuel Praga
Nephrology Service, University Hospital 12 de Octubre, Madrid Spain.
Professor Liz Lightstone
Consultant Nephrologist, Department of Medicine, Imperial College London.
Agenda
View the programme
Registration, tea and coffee
Welcome and introduction
Dr Allyson Egan, Honorary Lecturer, Consultant Nephrologist, University of Cambridge
Session one: Primary glomerulonephritis
Chair: Dr Allyson Egan, Honorary Lecturer, Consultant Nephrologist, University of Cambridge
Sensing self in autoimmune disease
Professor Hans-Joachim Anders, Head of Nephrology, University of Munich, Germany
Lessons from renal biopsy in glomerular disease
Professor Terence Cook, Professor of Renal Pathology, Imperial College London
Minimal change disease and idiopathic FSGS: manifestations of the same disease
Professor Jack Wetzels, Radboud University, Netherlands
Membranous glomerulopathy: Advancements in treatment and pathogenesis
Dr Manuel Praga, Hospital 12 de Octubre, Madrid, Spain
Update in clinical trials – TURING
Dr Lisa Willcocks, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals NHS Foundation Trust and Dr Megan Griffith, Imperial College Healthcare NHS Trust
Session two: Immune base disease
Chair: Professor Lorraine Harper, Professor of Nephrology, University of Birmingham
A personalised treatment for IgA nephropathy considering pathology and pathogenesis
Professor Rosanna Coppo, Director of Nephrology, Città della Salute e della Scienza di Torino, Regina Margherita Hospital, Turin, Italy
Updates in clinical trials in IgAN
Professor Jonathan Barratt, University of Leicester and Professor Fred Tam, Imperial College London
What’s new in lupus nephritis?
Professor Liz Lightstone, Professor of Renal Medicine, Imperial College London
Lunch
Session three: Case based discussion
Chair: Dr Tina Chrysochou, President, Nephrology Section, Royal Society of Medicine
Dual B-cell therapy and introduction to COMBIVAS trial
Dr Rachel Jones, Consultant Nephrologist, Cambridge University Hospitals NHS Foundation Trust
An update on complement related renal disease
Professor Neil Sheerin, Newcastle University
Complement inhibition in renal disease: Current therapeutic strategies
Dr Alexandre Karras, Nephrologist, Georges Pompidou European Hospital, France
Tea and coffee break
Session four: Understanding autoimmunity
Chair: Professor Bruce Hendry, Professor, King's College London, Past president, Nephrology section
Exploration of the role of plasma exchange and complement therapy in vasculitis
Professor David Jayne, University of Cambridge
Expert panel discussion
Case presentations
Closing remarks
Close of meeting
Sponsors
Location
Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom
Other events of interest
Medical apps: Mainstreaming innovation
This event on medical apps will examine the growing role that apps are playing in healthcare delivery.
Rare diseases and the kidney
This high quality meeting will bring experts from a wide variety of rare disease areas together to present the latest updates and developments in rare diseases.
Human 'guinea pigs' or privileged pioneers? Compassionate use of experimental treatments
This meeting will offer much-needed education on (and discussion of) the concept of ‘compassionate use,’ at the boundary between medical research and clinical practice.